Yuichi Imai

685 total citations
23 papers, 297 citations indexed

About

Yuichi Imai is a scholar working on Reproductive Medicine, Obstetrics and Gynecology and Oncology. According to data from OpenAlex, Yuichi Imai has authored 23 papers receiving a total of 297 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Reproductive Medicine, 9 papers in Obstetrics and Gynecology and 7 papers in Oncology. Recurrent topics in Yuichi Imai's work include Endometrial and Cervical Cancer Treatments (9 papers), Ovarian cancer diagnosis and treatment (9 papers) and Intraperitoneal and Appendiceal Malignancies (3 papers). Yuichi Imai is often cited by papers focused on Endometrial and Cervical Cancer Treatments (9 papers), Ovarian cancer diagnosis and treatment (9 papers) and Intraperitoneal and Appendiceal Malignancies (3 papers). Yuichi Imai collaborates with scholars based in Japan, United States and Indonesia. Yuichi Imai's co-authors include Keiichi Fujiwara, Kosei Hasegawa, Yuji Ikeda, Sho Sato, Kazuhiro Kakimi, Hirokazu Matsushita, Taigo Kato, Etsuko Miyagi, Yusuke Nakamura and Naofumi Takamatsu and has published in prestigious journals such as Journal of Clinical Oncology, Clinical Cancer Research and British Journal of Cancer.

In The Last Decade

Yuichi Imai

20 papers receiving 291 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yuichi Imai Japan 10 136 109 84 52 40 23 297
Shiro Takamatsu Japan 8 134 1.0× 273 2.5× 139 1.7× 93 1.8× 47 1.2× 26 413
Valerie Heong Singapore 10 107 0.8× 135 1.2× 52 0.6× 74 1.4× 9 0.2× 25 243
Jake J. Reske United States 9 197 1.4× 48 0.4× 87 1.0× 77 1.5× 30 0.8× 15 308
Moito Iijima Japan 8 152 1.1× 78 0.7× 42 0.5× 92 1.8× 20 0.5× 18 315
Milja Kaare Finland 9 149 1.1× 148 1.4× 60 0.7× 17 0.3× 71 1.8× 14 335
Alison Freimund Australia 8 139 1.0× 276 2.5× 57 0.7× 126 2.4× 29 0.7× 11 375
Shweta S. Chavan United States 9 139 1.0× 142 1.3× 65 0.8× 24 0.5× 16 0.4× 21 320
Sherman Lau Canada 5 83 0.6× 202 1.9× 124 1.5× 90 1.7× 15 0.4× 6 372
Sho Sato Japan 12 117 0.9× 157 1.4× 101 1.2× 132 2.5× 19 0.5× 32 411

Countries citing papers authored by Yuichi Imai

Since Specialization
Citations

This map shows the geographic impact of Yuichi Imai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuichi Imai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuichi Imai more than expected).

Fields of papers citing papers by Yuichi Imai

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yuichi Imai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuichi Imai. The network helps show where Yuichi Imai may publish in the future.

Co-authorship network of co-authors of Yuichi Imai

This figure shows the co-authorship network connecting the top 25 collaborators of Yuichi Imai. A scholar is included among the top collaborators of Yuichi Imai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yuichi Imai. Yuichi Imai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
Nishio, Shin, Kazuhiro Takehara, Shinya Sato, et al.. (2024). Re-administration of platinum-based chemotherapy for recurrent endometrial cancer: an ancillary analysis of the SGSG-012/GOTIC-004/Intergroup study. International Journal of Clinical Oncology. 29(10). 1594–1601.
4.
Matsuura, Motoki, Yoko Nishimura, Yuichi Imai, et al.. (2023). Nationwide trends in and regional factors associated with minimally invasive hysterectomy for benign indications in Japan. European Journal of Obstetrics & Gynecology and Reproductive Biology. 289. 129–135. 10 indexed citations
5.
Suzuki, Kaori, Yuko Watanabe, Yuichi Imai, & Yukie Yamaguchi. (2023). Eyelid and Vaginal Adhesions as Severe Sequelae of Toxic Epidermal Necrolysis. Cureus. 15(7). e41496–e41496. 1 indexed citations
6.
Mun, Se‐il & Yuichi Imai. (2022). Emergence of Global Terminal Operator and its Welfare Effects. SSRN Electronic Journal. 3 indexed citations
7.
Suzuki, Yukio, et al.. (2021). Inspection for micrometastasis is essential for predicting the prognosis of serous endometrial intraepithelial carcinoma: Case report and literature review. Journal of obstetrics and gynaecology research. 47(12). 4484–4489. 2 indexed citations
8.
9.
Hasegawa, Kosei, Muneaki Shimada, Satoshi Takeuchi, et al.. (2020). A phase 2 study of intraperitoneal carboplatin plus intravenous dose-dense paclitaxel in front-line treatment of suboptimal residual ovarian cancer. British Journal of Cancer. 122(6). 766–770. 4 indexed citations
10.
Hasegawa, Kosei, Yuji Ikeda, Yuichi Imai, et al.. (2018). Phase I Study of Multiple Epitope Peptide Vaccination in Patients With Recurrent or Persistent Cervical Cancer. Journal of Immunotherapy. 41(4). 201–207. 24 indexed citations
11.
Imai, Yuichi, Kosei Hasegawa, Hirokazu Matsushita, et al.. (2018). Expression of multiple immune checkpoint molecules on T�cells in malignant ascites from epithelial ovarian carcinoma. Oncology Letters. 15(5). 6457–6468. 39 indexed citations
12.
Ikeda, Yuji, Kazuma Kiyotani, Poh Yin Yew, et al.. (2017). Clinical significance of T cell clonality and expression levels of immune-related genes in endometrial cancer. Oncology Reports. 37(5). 2603–2610. 34 indexed citations
13.
Nishikawa, Tadaaki, Koji Matsumoto, Kenji Tamura, et al.. (2017). Phase 1 dose‐escalation study of single‐agent veliparib in Japanese patients with advanced solid tumors. Cancer Science. 108(9). 1834–1842. 23 indexed citations
14.
Matsushita, Hirokazu, Kosei Hasegawa, Katsutoshi Oda, et al.. (2017). The frequency of neoantigens per somatic mutation rather than overall mutational load or number of predicted neoantigens per se is a prognostic factor in ovarian clear cell carcinoma. OncoImmunology. 6(8). e1338996–e1338996. 20 indexed citations
15.
Ikeda, Yuji, Jae‐Hyun Park, Takashi Miyamoto, et al.. (2016). T-LAK Cell-Originated Protein Kinase (TOPK) as a Prognostic Factor and a Potential Therapeutic Target in Ovarian Cancer. Clinical Cancer Research. 22(24). 6110–6117. 64 indexed citations
16.
Yoshida, Hiroyuki, Yuichi Imai, & Keiichi Fujiwara. (2016). Combination chemotherapy with docetaxel and carboplatin for elderly patients with endometrial cancer. Molecular and Clinical Oncology. 4(5). 783–788. 10 indexed citations
17.
Ikeda, Yuji, Kosei Hasegawa, Daisuke Shintani, et al.. (2015). The Risk of Ovarian Malignancy Algorithm (ROMA) as a Predictive Marker of Peritoneal Dissemination in Epithelial Ovarian Cancer Patients. Oncology Research and Treatment. 38(6). 276–281. 4 indexed citations
18.
Nakamura, Tomomi, Yuichi Imai, Tomoko Nagata, et al.. (2015). Efficacy of estrogen replacement therapy (ERT) on uterine growth and acquisition of bone mass in patients with Turner syndrome. Endocrine Journal. 62(11). 965–970. 33 indexed citations
19.
Kawakami, Yuji, et al.. (2007). MEASURED FUNGAL INDEX DETERMINED USING FUNGAL GROWTH AND COMPUTED FUNGAL INDEX BASED ON TEMPERATURE AND RELATIVE HUMIDITY IN HOUSES. 2 indexed citations
20.
Ozawa, Takashi, et al.. (1999). Low pH and aluminum tolerance ofBradyrhizobiumstrains isolated from acid soils in Indonesia. Soil Science & Plant Nutrition. 45(4). 987–992. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Shiro Takamatsu Breakdown of academic impact, for papers by Valerie Heong Breakdown of academic impact, for papers by Jake J. Reske Breakdown of academic impact, for papers by Moito Iijima Breakdown of academic impact, for papers by Milja Kaare Breakdown of academic impact, for papers by Alison Freimund Breakdown of academic impact, for papers by Shweta S. Chavan Breakdown of academic impact, for papers by Sherman Lau Breakdown of academic impact, for papers by Sho Sato
Rankless by CCL
2026